In a significant move to align U.S. practices with international standards, the Centers for Disease Control and Prevention (CDC) has revised its CDC childhood vaccine schedule, emphasizing transparency, informed consent, and a more focused approach to protecting children from serious diseases. The Department of Health and Human Services (HHS) announced on January 5, 2026, that Acting CDC Director Jim O’Neill has signed a decision memorandum adopting recommendations from a comprehensive scientific assessment of childhood immunization practices. This action follows a December 5, 2025, Presidential Memorandum from President Trump directing HHS and CDC to review how peer developed nations structure their childhood vaccination schedules and update the U.S. version if superior approaches are identified abroad.
The Department of Health and Human Services (HHS) announced on January 5, 2026, that Acting CDC Director Jim O’Neill has signed a decision memorandum adopting recommendations from a comprehensive scientific assessment of childhood immunization practices. This action follows a December 5, 2025, Presidential Memorandum from President Trump directing HHS and CDC to review how peer developed nations structure their childhood vaccination schedules and update the U.S. version if superior approaches are identified abroad.
The assessment, which compared U.S. recommendations with those of 20 peer nations, revealed that the United States is an outlier in the number of diseases addressed (18 in 2024) and total recommended doses, often more than twice as many as some European countries like Denmark, which covers just 10 diseases. Despite this, many nations with fewer routine vaccines achieve strong child health outcomes, higher vaccination rates, and greater public trust through education rather than mandates.
Under the updated schedule, immunizations will be organized into three categories, all covered by insurance without cost-sharing: those recommended for all children, for high-risk groups or populations, and those based on shared clinical decision-making between parents and physicians. The core recommendations for all children include vaccines against measles, mumps, rubella, polio, pertussis, tetanus, diphtheria, Haemophilus influenzae type B (Hib), pneumococcal disease, human papillomavirus (HPV), and varicella (chickenpox).
HHS Secretary Robert F. Kennedy Jr. stated, “After an exhaustive review of the evidence, we are aligning the U.S. childhood vaccine schedule with international consensus while strengthening transparency and informed consent. This decision protects children, respects families, and rebuilds trust in public health.”
Acting Director O’Neill echoed this sentiment, noting, “The data support a more focused schedule that protects children from the most serious infectious diseases while improving clarity, adherence, and public confidence.”
The changes address a noted decline in public trust in health institutions from 2020 to 2024, which has contributed to falling childhood vaccination rates and increased risks of vaccine-preventable diseases. To bolster scientific rigor, the recommendations call for more gold-standard research, including placebo-controlled randomized trials and long-term observational studies, with HHS agencies tasked to fund these efforts.
CMS Administrator Dr. Mehmet Oz emphasized accessibility: “All vaccines currently recommended by CDC will remain covered by insurance without cost sharing. No family will lose access. This framework empowers parents and physicians to make individualized decisions based on risk, while maintaining strong protection against serious disease.”
Food and Drug Commissioner Dr. Marty Makary highlighted the role of trust: “Public health works only when people trust it. That trust depends on transparency, rigorous science, and respect for families. This decision recommits HHS to all three.”
National Institutes of Health Director Dr. Jay Bhattacharya added, “Science demands continuous evaluation. This decision commits NIH, CDC, and FDA to gold standard science, greater transparency, and ongoing reassessment as new data emerge.”
HHS and CDC plan to collaborate with state health agencies, physician groups, and other partners to implement the updates and educate parents and clinicians. A fact sheet detailing the changes is available on the HHS website.
This revision marks a step toward harmonizing U.S. immunization strategies with global best practices, potentially enhancing vaccine uptake and overall child health in the coming years. For more information, visit the HHS Press Room or consult with your healthcare provider.
